United Healthcare Issues Prior Notification Requirement for Myriad's BRACAnalysis Test
August 26, 2009
United Healthcare Issues Prior Notification Requirement for Myriad's BRACAnalysis Test
By instituting a prior notification policy and placing Myriad in charge of determining which patients get tested, United Healthcare can monitor more closely which of its policy holders are receiving testing on BRACAnalysis.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Myriad Defends Policy of Urging Docs to Genetically Counsel BRACAnalysis Customers
February 10, 2010 / Pharmacogenomics Reporter - Myriad Developing Companion Diagnostic for Cephalon
March 28, 2012 / GenomeWeb Daily News - In Australian BRCA Patent Challenge, Plaintiffs Not Satisfied With Myriad's IP Gift
November 3, 2010 / Pharmacogenomics Reporter - Myriad Assures Investors of Strong Patent Position Despite ACLU Anti-Gene Patenting Lawsuit
March 10, 2010 / Pharmacogenomics Reporter - 'Isolated DNA' Definition May Be Biggest Barrier to Summary Judgment at Anti-Gene Patenting Hearing
February 3, 2010 / Pharmacogenomics Reporter